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This year’s ISMB conference, an annual event
organised by the International Society for Compu-
tational Biology (http://www.iscb.org) was the big-
gest ever, with over 1400 delegates. The venue was
also a ﬁrst, situated, as it was, in Copenhagen’s
Tivoli Gardens funfair. However there was still time
for the many satellite meetings that ﬂanked the
conference including the Bio Pathways conference,
the Bioinformatics Open Source Conference and the
Bio-Ontologies Conference.
Soren Brunak and Anders Krogh opened the
conference. They remarked that it was 30 years
since the Needleman-Wunsch algorithm was writ-
ten, but that things have not changed much, from
that time, in that the basic biological ideas are still
driving research. They also mentioned that there
had been 180 papers submitted to the conference all
of which had to be refereed and graded before
choosing the 38 speakers.
Only the keynote talks are covered in depth here
as all the other talks are covered in a special
supplement to the journal Bioinformatics. http://
bioinformatics.oupjournals.org/
The conference began with talks on Protein
Structure and Modelling. However, rather than
talks about protein structure prediction, these talks
were based much more on the biology of how
protein structure information can help our under-
standing of the evolution and function of proteins.
Chris Dobson (Cambridge University) opened the
conference with an excellent talk on Protein Fold-
ing, Molecular Evolution, and Human Disease.H e
explained that, given the right circumstances, any
protein will form ﬁbrils similar to those found in
BSE or Alzheimer’s.
Proteins seem to fold and unfold all the time,
which can cause problems for structure determina-
tion in protein crystallography and NMR, as
proteins made under different circumstances often
have different structures. In the densely packed
environment of the cell, folding and unfolding may
form part of a switch mechanism, or chaperones
may be involved to help a protein to fold into a
particular structure.
Aggregations or amyloid structures are respon-
sible for many diseases e.g. Alzheimers, New
variant CJD (related to BSE), Type II diabetes etc.
Apparently, by the age of 60 we will all develop
some sort of aggregate, but hopefully they should
be disease free (asymptomatic). 16 diseases caused
by amyloid structures have now been identiﬁed (20
if diseases such as Parkinsons are included). For
example, two point mutations in Lysozyme allow it
to form disease-causing ﬁbrils, composed of many
parallel beta sheets.
The major breakthrough came when one of
Chris’ students was working on PI3 Kinase NMR,
when he went for a long weekend (160 hours). On
his return, the trace had disappeared almost to
nothing. So they looked to see what had happened
to the protein and found that it had formed ﬁbrils.
This was a complete surprise as it wasn’t a disease
causing protein and so was not expected to form
ﬁbrils. After examining the ﬁbrils they discovered
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beta sheets wrapped around each other in a helical
formation. These might be useful as nanotubes!
Chris believes that the ability to form ﬁbrils is
a character of all proteins, for example, even myo-
globin, in its less soluble form, produced amyloid
ﬁbres. In fact all proteins they have tried have
produced ﬁbrils, given the correct circumstances,
and any polypeptide chain if not chaperoned, or
controlled, could form ﬁbrils.
There appears to be an initial time limiting step,
as, like crystallisation, ﬁbril formation needs a
nucleation, or seeding, step. This explains the
rapid onset of diseases such as BSE after the ﬁrst
symptoms are noticed, as after the initial contam-
ination with ‘‘seed’’ proteins there is a slow
‘‘incubation’’ period until enough plaques are
formed to cause symptoms. After these ﬁrst signs
the growth of the ﬁbrils takes place rapidly,
especially as the intermediate form of the ﬁbril is
the most ‘‘contagious’’. Initial aggregates rather
than the ﬁbrils are the real seeds. At this stage they
are toxic and may lead to apoptosis, thus ridding
the body of a diseased cell, although this is not
always a good thing, as even more ‘‘seed’’ forming
ﬁbrils may be released, to be taken up by other
cells.
The reason that age seems to be a factor in many
of these amyloid diseases is that over the years there
is an increased risk that something will go wrong
with the folding of a protein, thus forming a
nucleation seed. However, some proteins are more
likely to aggregate than others, due to sequence and
cellular circumstance. For example, some mutated
proteins aggregate faster than others from a single
point mutation. If, for example, the mutation is in
the C terminus, then it is more likely to cause
protein aggregation, even though it may not have
much affect on the folding. The position and
‘‘biology’’ of a protein is also important, as for
example, in vitro, myoglobin will aggregate more
quickly than prions, yet there is no myoglobin
aggregate disease. Therefore, whether a protein
forms aggregates also depends on its position and
interactions within the cell. Selection against aggre-
gation may have increased the occurrence of
chaperones, as protein mixes do not form ﬁbrils.
Heterozygotes, with two alleles of a protein, may
also be at an advantage as mixed ﬁbrils are also less
likely, so even sexual reproduction plays a role.
Chris believes that the whole of evolution and
biology is one huge strategy to keep organisms from
becoming massive balls of ﬁbrils as if we were to
live long enough that is how we would end up!
All of this was discovered because someone had a
long weekend!
The rest of the section was an interesting mix of
different aspects of protein structure. Gordana Apic
(MRC Laboratory of Molecular Medicine) gave us
an Insight into Domain Combinations. Potentially
there are 180 000 pairwise combinations of SCOP
domains, but only 1,000 of these are found in
20 000 multidomain proteins from 40 species.
Indeed, 60% of domains have only one known
combination partner. The domain order is highly
conserved within protein families. Stephen Mo ¨ller
(EBI) spoke about predicting not only G protein
coupled receptors, but also their speciﬁcity, using
‘‘SPEXS’’ (http://ep.ebi.ac.uk/, http://www.ebi.ac.uk/
ycroning/coupling.html). Gianluca Pollastri (UC
Irvine & Bologna) used bi-directional neural network
architectures and evolutionary information to predict
interaction positions between proteins, as structure
tends to be more conserved than sequence (http://
promoter.ics.uci.edu/BRNN-PRED/). Tobias Mu ¨ller
(Deutsches Krebsforschungszentrum) also combined
structure prediction with sequence searching, but this
time used transmembrane domain speciﬁc matrices in
order to facilitate the search for homologous trans-
membrane proteins (http://www.dkfz.de/tbi/people/
tmueller). Michael Lappe (EBI) used a combination
of structure, in the form of fold information, and
protein interaction data to predict function,
although the method is still very much in develop-
ment (http://www.ebi.ac.uk/ylappe/FoldPred).
Chris Sander (Whitehead Institute) gave the
keynote talk for the Sequence Motifs, Alignments
and Families Section. He introduced his talk on
Structural Genomics, by pointing out what was to
be the overwhelming take-home message of the
conference – that what we (Bioinformaticians as
well as Biologists) are trying to do is answer
Biological questions. He hoped that soon we
would be able to model the ‘e-cell’ and then the
‘e-organ’; model the perturbation of the system
caused by drugs; decipher neurobiology, and com-
bine it all into systems biology where not just the
whole organism, but whole ecosystems could be
modelled.
According to Chris Sander, structural genomics is
only a part of what is needed. Eventually he would
like to be able to see the structure of every
biological molecule, from which we would be able
to fully understand the function of that molecule.
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consuming to obtain. Sander suggests that rather
than obtaining the structure of every molecule, we
need only determine the structure of one molecule
per protein family, or maybe even superfamily,
using homology to predict the structure of the other
family members.
Even at the level of 30% sequence identity, there
are 4000 sequences for all the families of the model
organisms in Pfam. However, not all families are
represented in Pfam, so the actual number may be
closer to 4000r4. Producing this number of
representative structures will take as much coordi-
nation as sequencing the human genome and to
ensure availability to everyone, something that Bill
Clinton and Tony Blair agreed to, it will involve
much public funding. At present there are 7+ pilot
centres that have started work, with other teams
trying to predict function from structure (e.g. if the
substrate size can be predicted from the substrate
binding site, this narrows down the potential
functions the molecule may have), which can then
be tested in the lab.
The second part of the talk (Cell) concerned
linking expression proﬁling with pathway data-
bases, so that genes are not clustered just by
expression, but by position in a pathway. Producing
a functional distance pathway averaged into a
neighbour pathway makes it possible to pick out
‘‘activity centres’’ of clusters of genes. As an
example, Chris mentioned MYC, an enzyme that
did not share a transcription proﬁle with other
enzymes from the same pathway, but which formed
the nucleus of an activity centre. It was found that
this enzyme was regulated by methylation, showing
that enzymes within the same functional pathway
may have different methods of regulation.
Michael Wise (CCSR, Cambridge, UK) conti-
nued the session by championing low complexity
proteins, which are often ignored, as they are
difﬁcult to deal with. However, they still have
function, for example those involved in DNA
binding. He showed a method for modelling the
low complexity regions based on pattern matching
methods and was then able to categorise different
types according to structure and function.
The other three talks in the session all dealt with
regulation. Mathieu Blanchette (University of
Washington) presented an interesting promoter
prediction technique based on X
2 comparisons of
the number of expected occurrences of a sequence
over the number of sequences found. Fabian Model
(Epigenomics AG) differentiated between acute
lymphoblastic leukaemia (ALL) and acute myeloid
leukaemia (AML) by looking at the methylation
state of CpG dinucleotides in CpG islands, which
are responsible for expression regulation. Their
algorithm enabled the most discriminant sites to
be chosen. Giulio Pavesi (University of Milan)
explained the huge numbers involved in promoter
prediction. For example, if a pattern of m letters is
in all sequences studied and may have mutations at
any position, then there are 4
m possibilities. While
promoter regions are very small, e.g. m=6, this is a
tractable number, 4096 possibilities, but with a
signal length of 20, then it is in to the trillions
(109,951,1627,776 to be exact). He used sufﬁx trees
to ﬁnd planted promoter regions in simulated data,
but the method has not yet been tested on real data.
Monday began with David Eisenberg (UCLA)
giving the keynote talk for the Networks and
Modelling section, with a talk on Protein Interac-
tions. David explained that there were two types of
protein interaction, physical and functional. Physi-
cal interactions are where two proteins come into
actual contact. The Database of Interacting Pro-
teins (DIP) found at http://dip.doe-mbi.ucla.edu
contains details of interactions such as those
elucidated from yeast 2-hybrid data, as well as
data from literature searches. At present, yeast has
the largest physical interaction network in the
database, with Helicobacter pylori in second place.
In yeast, a protein may be involved with as many as
50 interactions, although the average is 3.5. The
highly connected genes are usually lethal, if deleted!
Surprisingly, there is very little overlap detected so
far in the physical interaction maps obtained from
different organisms, but these are by no means
complete yet.
Functional interactions group together proteins
that are from the same pathways. Of course,
proteins in functional groups can also be in the
same physical group. Two methods of predicting
whether genes are from the same pathway are
microarray clustering and phylogenetic clustering.
The two methods are similar, but phylogenetic
clustering, instead of looking to see if genes are
expressed in a similar pattern, looks to see if genes
are inherited in similar pattern, as genes from the
same pathway will tend to be inherited together. A
continuation of phylogenetic inheritance clustering
is the concept of the ‘‘gene neighbour’’. This is
especially true in prokaryotes, where genes found in
the same region of the chromosome, and therefore
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connected. Taking this a step further gives us the
‘Rosetta Stone’ situation, where proteins that
interact and are separate in some species have
fused into one protein in another species. In yeast,
many single proteins have been found that have
corresponding Rosetta Stone proteins in other
species.
Vincent Scha ¨cter (Hybrigenics) was interested in
predicting Protein Interaction Maps (PIM) for one
species based on what is known for a closely related
species. This appeared to work reasonably well, but,
as is often the case, a true validation dataset is
unavailable.
Dana Pe’er, (Hebrew University) who won the
award for best presentation, provided another
approach to predicting interaction networks, in
this case metabolic, signalling and regulatory net-
works. Their approach to Inferring Subnetworks
from Perturbed Expression Proﬁles was to compare
expression proﬁles from Saccharomyces cerevisiae
knock out mutants with those from the wild type,
under different perturbations, in order to determine
which genes are affected by the deleted gene.
First they adaptively discretize the expression
data into under expressed, baseline, and over
expressed, for each gene. Bootstrap analysis is then
performed to estimate the conﬁdence of the features
of the Bayesian networks. This gives levels of
signiﬁcance and conﬁdence to the various pairwise
interaction models, for example A upregulates B.
From these pairwise models, interactions with high
levels of conﬁdence are extracted and grouped into
subnetworks, representing cellular processes, such
as iron homeostasis, or amino acid metabolism.
These can then be visualized using ‘‘Pathway
Explorer’’. They emphasize that they are unable to
uncover all pathways this way but that those they
have predicted may help the bench scientist to focus
their research. For more information see http://
www.cs.huji.ac.il/labs/compbio/ismb01.
Laurence Hunter (National Cancer Institute) tried
a Bayesian method to improve clustering of micro-
array data but was unable to prove any increase in
performance, possibly due to the small size of test
data sets. Eran Segal (Stanford) integrated multiple
datatypes including function, and known promo-
ters, to help cluster microarray data. They found an
interesting set of 17 yeast genes induced by the
diauxic shift which are all involved in sugar
metabolism and which all have two or more binding
units for the MIG1 repressor. It had not previously
been known that these genes were regulated by
MIG1 (http://dags.stanford.edu/bio). Chen-Hsiang
Yeang (MIT) was able to classify tumour types
based on tissue speciﬁc gene regulation by ‘‘one
versus all support vector machine’’ classiﬁcation
(http://www.genome.wi.mit.edu/MPR/). Alexander
Zien (German National Research Center for Infor-
mation technology) described a method called
‘‘Centralization’’ for comparing microarray experi-
ments, based on the assumption that unless a cell is
undergoing activation, then approximately the same
number of genes will be upregulated as down
regulated. This assumption appears to hold true
over most cells as activation only occurs in a few
cell types in the body such as stem cells.
Bernardo Huberman (Hewlett Packard) gave an
interesting keynote talk on The Phenomenon of the
World Wide Web. The web is now growing
exponentially with at present almost 30 million
web sites. In 1998 only 147 million people used the
web, by 2000 this ﬁgure had grown to 400 million.
He showed a map of all the web sites in Finland
and how they interact. This map appears to be truly
random but a similar random map could be used to
represent Europe or America, as the rules, which
can be drawn from this map, can be applied to any
site linkage map. For example, the average number
of links between any 2 pages in the Finnish web
map is 4.2, the same as for any two pages in the
whole of Europe.
He introduced a Social Science approach to
searching the web. Social Science is concerned with
the links between people, such as who knows whom
on a University campus. A similar approach can be
taken with the www in that if we want to know
something we would ask someone who might know,
and if they don’t know then they ask someone else
until the question is answered. If we were to search
the web using the same approach we would ask a
website concerned with the area we are interested
in, that had many links. It will then ask all the sites
it has links with until the question is answered.
With a web of 10,000 sites, 50% of the web would
be covered in just 12 steps. More details are
available from http://www.hpl.hp.com/shl
Continuing in the promoter prediction theme
Derek Chiang (UC Berkeley) told us of a method of
looking for 5, 6, 7 and 8mers in the upstream
regions of genes, then calculating a mean expression
proﬁle for all the genes with that motif. If this value
differs signiﬁcantly from the mean taken over all
the genes, the motif may be a promoter. They have
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investigating many more potential promoters
(http://rana.lbl.gov). Anja von Heydebreck (Max-
Planck-Institute for Molecular Genetics) and Eric
Xing (UC Berkeley) were both trying to differen-
tiate between AML and ALL using microarrays.
Both used two-step procedures. Heydebreck used a
bipartite statistical analysis on only the highly
expressed genes and was able to differentiate
between AML and ALL, but also between the B
and T forms of ALL. Xing’s method involved
clustering all the data, choosing the genes which
were the most discriminatory and reclustering these,
with the last 2 steps being iterated up to 9 times. He
was also able to differentiate between AML and
ALL. Interestingly both methods found three
exceptions.
Tuesday morning saw the highlight of the
conference for me, which was the keynote talk for
Gene Structure, Regulation and Modelling by Sean
Eddy (Washington University) on The Modern
RNA World: Many Genes don’t Encode Proteins.
He started by mentioning that the competition for
the number of genes in the human genome
(GeneSweep), run from the Cold Spring Harbor
Laboratory, is only for the number of protein
coding genes, as Ewan Birney had felt that the
RNA genes would be too difﬁcult to assess. He also
mentioned the yeast paper ‘‘Life with 6,000 genes’’
by Goffeau et al., as this value does not include the
many RNA genes, such as the 275 tRNA genes.
However, RNA genes should not be underesti-
mated, as a C. elegans RNA of only 21 nucleotides
is lethal when deleted and is 100% conserved in
mouse and Drosophila. Sometimes, in what would
appear to be an ordinary looking gene with exons
and introns, we ﬁnd that the exons are not
conserved but the introns are. In the case of the
human UHG (U22 Host gene) ‘‘inside-out’’ gene,
the introns encode 8 stable snoRNAs, which are
spliced from the mRNA, while the resulting exons
are quickly degraded (Figure 1, Tycowski et al.,
1996).
RNAs can also play vital roles in pathways, such
as pRNA in bacteriophage w29, which forms part of
the phage rotary packaging motor. RNA genes may
even be disease genes; Prader Willi syndrome and
Cartilage–hair Hypoplasia are both caused by
mutations in RNA sequences. In the latter case,
they only discovered it was an RNA that was
responsible when they had narrowed down the
region on the chromosome to a short region in
which it was known that none of the protein coding
genes to be involved. However, an RNA gene (that
had already been sequenced for another reason) was
noticed and experiments showed that this was the
responsible gene.
RNA genes are often difﬁcult to detect as they
are very small (such as the C. elegans RNA
mentioned earlier); sometimes multicopy and redun-
dant; often not polyadenylated (EST libraries are
selected by poly-A); immune to frameshift errors or
nonsense mutations; have no open reading frame or
codon bias and often evolve rapidly.
Two recent screenings of E. coli have found 14
and 17 novel RNAs by either looking for promoters
and conserved regions between closely related
species, or by looking for conserved regions, then
using microarrays to detect if they are expressed.
Sean Eddy’s group have also screened E. coli,
ﬁnding another 7 novel RNAs not found by the
other methods, with another 200+ potential RNAs
still to be evaluated. This method involved compar-
ing E. coli to four other bacterial genomes using
Washington University’s BLASTn, then running
them through their QRNA program, to predict
possible conserved RNAs.
QRNA is based on context free grammars
(CFG), which are used to look for conserved
secondary structure pairings in the BLAST align-
ments. Context free grammars look at nested
pairwise correlations and can model all RNA
secondary structures except pseudoknots, where
the RNA crosses over on itself. QRNA appears to
be a useful tool in the hunt for RNAs but does need
several whole genomes, from species closely related
Figure . Inside-out genes? Human UHG (U22 host gene, white boxes) has no signiﬁcant ORFs, is not conserved with mouse
and is rapidly degraded. However, it has eight intron-encoded snoRNAs (shaded boxes), which are conserved with mouse
and are stable (Tycowski et al., 1996)
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conserved RNAs.
Sean Eddy left us with his vision of the modern
RNA world where RNA may be the material of
choice for cells, as small, highly speciﬁc, comple-
mentary RNAs are easy to produce by simply
duplicating a region of the antisense strand of the
target RNA, whereas to produce a protein to do the
same job would take years of evolution and would
be much less cost effective to the cell.
Sridhar Hannenhalli (Celera Genomics) was also
interested in promoter prediction but without the
help of microarray data. In humans almost half of
all genes and nearly all house keeping genes have
CpG islands in the promoter regions. Uwe Ohler
(University of Erlangen-Nu ¨rnberg) used physical
properties of DNA in his hunt for promoters.
Properties such as propeller twist and DNA bend-
ing stiffness may be calculated from trinucleotide
frequencies. In D. melanogaster known promoters
are found with an accuracy of 75% using this
method (http://www.fruitﬂy.org/sequence/drosophila_
datasets.html). Ammos Tanay (Tel-Aviv University)
introduced the concept of Genetic Networks, which
describe the interactions, such as promotion or
inhibition, between genes. By expanding networks
based on gene expression proﬁles they were able to
predict a novel yeast ergosterol transcription factor.
Carol Friedman (Columbia University, New York)
used Natural Language Processing (NLP) based on
MedLEE, an existing medical NLP system, to
extract information on molecular pathways from
whole articles. Although the method did not ﬁnd all
the relationships that a human expert found it did
ﬁnd some real relationships that the human had
missed. On a rather different note Steven Skiena
(State University, New York) described an algo-
rithm for Designing better Phages. This reduces the
number of restriction sites by exploiting the
redundancy inherent in the triplet code, so as to
increase the bacteriophages use as an antibacterial
agent.
Chris Burge from MIT presented the second
Chris Overton memorial lecture and was presented
with the Chris Overton Medal for Research by
Chris Overton’s widow. Christopher Burge is best
known for producing Genscan as part of his PhD.
His talk, entitled the Computational Analysis of
RNA Splicing, explained that there is still much that
we do not know about intron splicing and the
regulation of alternative splicing, which appears to
be very important in the human genome, where at
least half of genes may be alternatively spliced.
There are two main intron types. Those where the
splicing instructions are in the ends of the exons
(which can lead to exon slippage) and is the usual
method for human long intron splicing and those
which splice short introns where the information is
found in the intron ends. In worm and ﬂy these last
type are fairly constant, with an intron prediction
accuracy of 95%, although the position of the 3k
splice site can wobble. In humans and plants there
is much more variation in the intronic splice site
elements, so that intronic enhancers become more
important for accurate splicing. These are U rich in
Arabidopsis; GGG or U rich in human, and UA,
U or UGA rich in Drosophila. If the splice sites
are strengthened then these intronic enhancers
become unnecessary. He is currently developing
computational methods to predict intronic splicing
enhancers.
Vasileios Hatzivassiloglou (Columbia University)
revisited Natural Language Processing, with a mach-
ine learning approach, also based on MedLEE.
This method is able to not only extract relation-
ships between proteins and genes but due to the
large corpus of text, it can check and correct these
relationships. John Chuang (University of Illinois)
also used a method based on NLP, but to predict
genes. Potential start, stop, donor and acceptor sites
a r es c o r e da n dc o n v e r t e di n t oD i r e c t e dA c y c l i c
Graphs (DAGs). The shortest path through the
graph represents the predicted gene structure. Ezekiel
Adebiyi (University of Tu ¨bingen) introduced an
algorithm for ﬁnding approximate non-tandem
repeats. These are difﬁcult to ﬁnd, due to inser-
tions, deletions and mutations, which occur within
elements of the repeat. These repeats are of interest
as they may encode promoter regions or protein
domains. Ian Korf and Michael Brent (Washington
University) jointly presented ‘‘Twinscan’’ which
attempts to extend the gene prediction program
‘‘Genscan’’, by extending the model to include
homology, with different conservation models for
exons, introns UTRs etc. This appears to signiﬁ-
cantly increase the speciﬁcity of ‘‘Genscan’’. They
are currently working with EnsEMBL on the mouse
genome (http://genes.cs.wustl.edu).
Wednesday morning’s keynote in the Methods
section was by Gunnar von Heijne (Stockholm
University), who gave a very clear talk on Mem-
brane Proteins: From the Computer to the Bench and
Back. When trying to predict transmembrane
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brane HMM’’ (TMHMM) are better than hydro-
phobicity methods. TMHMM has a sensitivity of
over 98% when detecting transmembrane proteins,
achieving the correct topology 77% of the time.
However, if a number of prediction methods are
combined then the transmembrane proteins can be
predicted with 100% accuracy. These theoretical
predictions must be validated by wet lab work,
which in turn can help tune the predictive pro-
grams. Although, membrane predictions are now
reasonably accurate, much information on the
helical turning and packing of the amino acids is
still missing.
Daniel Huson (Celera Genomics) described
a Compartmentalized Shotgun Assembler. This
involves combining the publicly funded human
‘‘clone by clone’’ BAC’’ sequence data, with
Celera’s whole genome shotgun assembly data, to
produce a more complete coverage of the genome
than either method used separately could produce.
David States (Washington University) presented a
method, at least as accurate as a human expert, to
construct physical genomic maps. It can even cope
with variable clone length and markers of almost
identical molecular weight. Uri Keich presented a
very interesting and clear talk on behalf of Pavel
Pevzner (UC San Diego), on assembling ‘‘Double-
barrelled’’ data. This assembly method does not use
the normal ‘‘overlap-layout-consensus’’ methods
utilised by ‘‘Phrap’’, instead the reads are cut into
shorter overlapping pieces, which are assembled
using a Eulerian Superpath approach, to assign
reads to contigs. Repeats are not masked, but
rather used to help order contigs, even when there
are a number of identical repeats. This method
appears to perform very well, giving almost perfect
results with all bacterial genomes they looked at.
The only talk on mass spectrometry, was given by
Vineet Bafna (Celera Genomics) on ‘‘SCOPE’’.
‘‘SCOPE’’ is based on sequence alignment theory
to match peptide fragments to peaks produced by
Applied Biosystems’ new tandem mass spectro-
meters. They are presently using ‘‘SCOPE’’ to
identify 10,000 proteins a day, to an accuracy of
90–99%. James Borneman (UC Riverside) introduced
an algorithm to choose the minimum probe set to
discriminate between populations of microorgan-
isms in the ﬁeld (even detecting new ones), by DNA
ﬁngerprinting of rDNA. Ziv Bar-Joseph (MIT)
presented an algorithm, which orders the leaves in
a tree, or cluster, in a biologically meaningful way.
Using yeast cell cycle microarray data they were
able to correctly order the genes into cell cycle, and
cell cycle group order, which the original clustering
method could not do (http://www.psrg.lcs.mit.edu/
clustering/ismb01/optimal.html). David Venet (Uni-
versite ´ Libre de Bruxelles) gave a talk on a ‘‘Direct’’
method for separating cell types and proportions
from heterogeneous samples from colon cancer
patients, based on expression proﬁles, combined
with gene annotation.
Tandy Warnow (University of Texas, Austin)
opened the last session of the conference, which
was on Sequence and Phylogeny, with a talk on an
interesting approach to recreating phylogenies from
gene order data rather than gene sequence,
although at present the method cannot cope with
insertions, deletions and uneven gene content.
Eleazar Eskin (Columbia University) introduced
a method based on mutation matrices, which can
be used on any sequence type, to ﬁnd a prob-
able ancestral sequence (http://www.cs.columbia.
edu/compbio/mca/). Luay Nakhleh (University of
Texas, Austin) used a ‘‘Dish Covering’’ algorithm
to reconstruct phylogenetic trees. It performed
better than Neighbour Joining (NJ) with sequences
of over 6000 nucleotides, but NJ performed best
with sequences below 4000. Dirk Husmeier
(Biomathematics and Statistics Scotland) gave the
last talk of the conference. He presented an upgrade
to ‘‘TOPAL’’, a method for studying recombina-
tion. This new measure obtains a tree from a
multiple sequence alignment, along which a window
is passed and as the window moves new trees
are calculated. A difference in the trees indicates
differences in the evolution of the sequence on
either side of a recombination event (http://www.
bioss.ac.uk/ydirk).
The conference was brought to a close with a
thank you to everyone involved in the organisation
of the conference (to which I add my own thanks)
and by the presentation of the awards for best
poster and talk. Dana Pe’er won the best talk, while
Boris Lenhard and Wyeth Wasserman (Karolinska
Institute, Stockholm) won the best poster with
GeneLynx: A Comprehensive and Extensible Portal
to the Human Genome. ‘‘GeneLynx’’ is based on
the idea that there should be a central web resource
for all human genes, with each gene having a page
with links to all the information available on that
gene. More details are available from http://www.
genelynx.org.
ISMB2001 was an excellent conference, with a
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covering a wide range of areas, with a particularly
strong representation from the ﬁeld of microarrays,
today’s ‘hot topic’. So what will next year’s hot
topic be? Still microarrays, or perhaps mass
spectrometry and proteomics?
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